HOODIE (HOODIE) Spotlight — July 11, 2026

In-depth HOODIE spotlight: $0.0223 price, +1156.8% 24h change, technical analysis, pros/cons, and market outlook.

HOODIE HOODIE Spotlight July 11 2026

Rank #791 | $0.0223 | +1156.8% 24h

Is Ethereum a good investment? The evidence is mixed. On-chain activity remains historically high, but price action and supply dynamics have turned neutral to bearish since early 2026.

ETH trades at $1,794 as of July 11, 2026, up 3.09% in 24 hours, with a $216.79 billion market cap and $17.08 billion in daily volume, per CoinMarketCap. That price sits 73% below its November 2021 all-time high of roughly $4,800.

Bull Case: Network Usage Remains Elevated

Daily active addresses on Ethereum mainnet averaged 837,200 over the 30 days ending March 2026, per on-chain data. That's up 82% from five years ago and 1,135% from ten years ago. The network peaked at 1.3 million active addresses on January 16, 2026, before cooling to about 945,000, still ahead of Layer-2 rivals Arbitrum, Base, and OP Mainnet, according to Etherscan.

The 100-day moving average of active addresses hit 469,303 in early 2026, matching levels last seen during the 2021 bull market. That suggests sustained user engagement despite price weakness. The 30-day moving average remains near 450,000 as of July 2026, comparable to 2025 bull market levels.

Institutional capital has moved in too. Spot ETFs for Bitcoin, Ethereum, Solana, and XRP opened the door, per market analysis from March 2026. Tokenization of real-world assets on Ethereum is picking up, and some analysts project a $5 trillion network valuation; Fundstrat co-founder Tom Lee estimates that implies a token price near $41,300 based on the current circulating supply of about 121 million coins.

Bear Case: Supply Growth and Price Decay

Ethereum's supply has grown by roughly 60,000 ETH since the start of 2026, according to CryptoQuant. That reverses the deflationary trend that held through much of 2024 and 2025. Low gas fees, dropping to 1 Gwei, have cut the burn rate and pushed net issuance positive.

With a circulating supply of approximately 120.7 million ETH, the network is no longer burning more than it creates. Price action has been weak: Ether traded at $1,746 on July 11, down 1.56% in 24 hours, facing resistance at $1,800.

The global crypto market cap stood at $2.2 trillion on July 11, up 1.43% from the prior day. Altcoin market cap excluding Bitcoin and Ethereum shed 23% in the first half of 2026, dropping to $666 billion, as capital rotated into Bitcoin and stablecoins, per market data compiled as of July 9.

On-chain activity has also been volatile. Daily active addresses on Ethereum slid from 1,329,193 on February 7 to 746,062 on March 3, 2026, a drop of roughly 45% in under a month. The 14-day moving average of active addresses peaked near 795,000 in early February 2026 and has since declined, per Glassnode data.

Bitcoin's daily active addresses have dropped from about 1.12 million in May 2021 to approximately 624,000 currently, a 44% decline. That points to a broader slowdown in network engagement across major chains, not just Ethereum.

Valuation and Tokenomics

Ethereum's market cap of $216.79 billion is 9.49% of the total crypto market. Bitcoin dominates at 56.4% with a $64,163 price as of July 11.

The fully diluted valuation equals the circulating market cap since Ethereum has no hard cap on total supply. Network revenue offers a rough proxy for a price-to-sales figure: daily revenue on Ethereum mainnet was about $39,000 as of July 11, a $14 million annualized run rate.

Metric to watch: the 30-day moving average of daily active addresses, which stood near 450,000 in July 2026. A drop below 400,000 would point to waning engagement and further price downside, while a climb above 500,000 that holds would signal renewed adoption and could support a rally toward the $1,850–$1,900 resistance zone.

Price
$0.0223
Market Cap
$22.3M
Rank
#791
24h Change
+1156.8%
7d Change
+0.0%
ATH
$0.0319

What Is HOODIE?

HOODIE solves no technical problem. It exists to capture community energy and speculative attention around the launch of Robinhood Chain, a new Ethereum Layer-2 network. The token launched on July 10, 2026, as a meme-style asset with a hoodie-wearing mascot and the tagline "the hood stays on."

It trades on Uniswap against Wrapped Ether, with no presale, no vesting schedule, and no promised utility. As of July 11, 2026, HOODIE has a circulating supply of 1 billion tokens, a market cap of approximately $20.67 million, and 24-hour trading volume of $45.4 million, according to CoinMarketCap.

Bitcoin is a decentralized store of value with a fixed supply cap of 21 million. Ethereum is a smart contract platform hosting thousands of decentralized applications and processing roughly 15 transactions per second on its base layer. HOODIE is neither.

HOODIE has no fixed supply cap; total supply currently sits at 1 billion tokens, with no utility beyond speculation. It doesn't inherit Bitcoin's security model or Ethereum's developer ecosystem. Instead, its value comes from the Robinhood brand, where users and employees are known as "Hoodies," and from community sentiment on a chain that launched just 10 days earlier, on July 1, 2026. The token's 1,847% price surge in its first 24 hours reflects that speculative dynamic, not fundamental adoption.

Key Features

  • Robinhood Chain Launch: HOODIE is a memecoin launched on Robinhood Chain, a permissionless Ethereum Layer-2 network built with Arbitrum technology.
  • Meme Token Identity: HOODIE belongs to the Robinhood Chain Meme category and is designed around meme-driven community participation rather than utility-based token functions.
  • Ethereum Settlement: Robinhood Chain uses Ethereum for data availability and ETH as its native asset, linking HOODIE activity to Ethereum’s security ecosystem.
  • Low-Cap Market Profile: CoinGecko data shows HOODIE has a market capitalization of approximately $22.3 million, placing it among smaller-cap crypto assets.
  • Recent Price Move: CoinGecko data shows HOODIE trading at $0.0223 after a 24-hour price increase of 1,156.8% as of the latest market snapshot.

Use Cases

  • Meme applications and use cases
  • Robinhood Ecosystem applications and use cases
  • Robinhood Chain Meme applications and use cases

Pros & Cons

✅ Pros

  • Dong Chong Xia Cao (Cordyceps sinensis): A Comprehensive Introduction
  • Introduction and Origin
  • Dong Chong Xia Cao (冬蟲夏草), which translates to "winter worm, summer grass" in Chinese, is one of the most valued medicinal fungi in traditional Chinese medicine (TCM)-
  • . The species is scientifically known as Cordyceps sinensis (Berk.) Sacc. and has recently been reclassified as Ophiocordyceps sinensis-
  • . It belongs to the family Clavicipitaceae-
  • This remarkable organism is a fungus-insect complex formed when the fungal fruiting body (the "grass") parasitizes and grows out of the larvae of ghost moths (family Hepialidae) (the "worm")-
  • . In the fall, fungal mycelia infect the caterpillar, and by early summer of the following year, the fungus kills the caterpillar and releases spores from the fruiting body that emerges from the ground-
  • The natural habitat of Cordyceps sinensis is primarily the Qinghai–Tibetan Plateau and surrounding Himalayan areas at high altitudes of 3,000 to 5,000 meters above sea level-
  • . Its rarity and the difficulty of harvesting it in the wild make natural Cordyceps extremely expensive-
  • . Consequently, mycelial strains have been isolated from natural Cordyceps and are now manufactured in large quantities through fermentation technology, commonly sold as health food products and dietary supplements-
  • Traditional Uses in Chinese Medicine
  • In TCM, Dong Chong Xia Cao is considered to have a sweet taste and neutral nature-
  • . Its primary traditional functions are to replenish the kidney and soothe the lung-
  • . It is traditionally used to treat a wide range of conditions including:
  • Fatigue and asthenia after severe illness-
  • Night sweating-
  • Hyposexuality and sexual dysfunction-
  • Respiratory diseases and cough-
  • Kidney dysfunction and renal failure-
  • Hyperglycemia and hyperlipidemia-
  • Arrhythmias and other heart diseases-
  • Liver disease-
  • It is also valued for restoring energy, promoting longevity, and improving quality of life-
  • , and is used as an adaptogen and immune stimulant-
  • . Other traditional applications include arresting bleeding, resolving phlegm, and stopping cough-
  • Bioactive Compounds
  • Cordyceps sinensis contains a rich array of bioactive components responsible for its pharmacological effects. The principal active compounds include:
  • Compound Class Examples
  • Nucleosides Cordycepin (3'-deoxyadenosine), adenosine, guanosine, inosine, uracil, uridine-
  • Acids Cordycepic acid-
  • Polysaccharides Cordyceps polysaccharides (PS) and exopolysaccharides (EPS)-
  • Sterols Various sterols-
  • Others Proteins, peptides, all essential amino acids, fatty acids, vitamins-
  • Fresh, natural Cordyceps contains a lower content of nucleosides than dry, processed, or cultured Cordyceps-
  • . These compounds act mainly by modulating key signaling pathways, including NF-κB, MAPK, TLR4/MyD88, PI3K/Akt, JAK/STAT, and Nrf2/HO-1-
  • Pharmacological Activities
  • Extensive pharmacological studies have demonstrated that Cordyceps sinensis possesses a wide range of biological activities-
  • Immunomodulatory Effects
  • Immunomodulation is one of the most thoroughly investigated and therapeutically promising properties of Cordyceps-
  • . It can help regulate immune system function-
  • Anti-Inflammatory Properties
  • Cordycepin, cordycepic acid, polysaccharides, and sterols exert significant protective effects in inflammation-related diseases, including respiratory diseases, autoimmune disorders, neuroinflammatory conditions, and metabolic and gastrointestinal syndromes-
  • Antioxidant Effects
  • Certain chemicals in Cordyceps have antioxidant effects that may help protect cells in the kidneys and other organs-
  • Antitumor and Anticancer Potential
  • Preclinical studies have shown antitumor effects-
  • . Some researchers believe it may have anti-cancer benefits by inducing cancer cell death (apoptosis)-
  • Other Activities
  • Additional pharmacological effects include antiplatelet, antidiabetic, radioprotective, antimicrobial, and aphrodisiac properties-
  • Clinical Evidence and Modern Research
  • While in vitro and animal studies suggest potential therapeutic applications, well-controlled clinical trials are lacking-
  • . However, some clinical research has been conducted:
  • Chronic Obstructive Pulmonary Disease (COPD): Cordyceps has shown promising clinical efficacy in treating COPD by targeting inflammation, apoptosis, and oxidative stress-
  • Chronic Bronchitis: A preparation of C. sinensis (Bailing capsule, Cs-C-Q80) improved airway inflammation in patients with chronic bronchitis by modulating inflammatory factors-
  • Primary Insomnia: A randomized clinical trial investigated the effectiveness of fermented Cordyceps broth for primary insomnia-
  • Kidney Disease: Cordyceps has been used in patients with chronic renal failure at doses of 3 to 6 g/day for periods ranging from days to years-
  • Mycobacterium Avium Complex Pulmonary Disease: Clinical trials are ongoing to evaluate whether Cordyceps capsules can prevent recurrence-
  • Exercise Performance: One study found that Cordyceps sinensis (CordyMax Cs-4) supplementation does not improve endurance exercise performance-
  • Safety, Side Effects, and Interactions
  • Common Side Effects
  • The most common side effects include:

❌ Cons

  • Dry mouth-
  • Contraindications and Precautions
  • Pregnancy and Lactation: Information regarding safety and efficacy is lacking-
  • Drug Interactions: Cordyceps may enhance the adverse/toxic effects of anticoagulant and antiplatelet agents (blood thinners such as warfarin)-
  • Blood Sugar: Cordyceps can lower blood sugar levels and may interact with antidiabetic medications or insulin-
  • Toxicology
  • Cordyceps is generally considered safe-
  • . No major side effects have been reported in most studies-
  • . However, mild GI discomfort and allergic reactions have been reported-
  • Conclusion
  • Dong Chong Xia Cao (Cordyceps sinensis) is a unique and highly valued medicinal fungus in traditional Chinese medicine, formed by the parasitic relationship between a fungus and the larvae of ghost moths. Native to the high-altitude regions of the Qinghai–Tibetan Plateau, it has been used for centuries to treat fatigue, respiratory and kidney disorders, sexual dysfunction, and various other conditions.
  • Its pharmacological effects are attributed to a diverse range of bioactive compounds, including cordycepin, cordycepic acid, polysaccharides, and sterols, which exhibit immunomodulatory, anti-inflammatory, antioxidant, and antitumor activities. While preclinical studies are promising, well-controlled clinical trials are still needed to fully establish its efficacy in humans.
  • Due to the rarity and high cost of natural Cordyceps, most products today are derived from cultivated mycelial strains. The herb is generally considered safe, though it may interact with anticoagulant and antidiabetic medications. As with any supplement, it is advisable to consult a healthcare provider before use.

Price Outlook

HOODIE trades at $0.0223, $0.0096 below its all-time high of $0.0319. The ATH marks the nearest confirmed resistance; the data shows no validated support level below the current price. A break above $0.0319 would open a new price discovery phase, while a drop below $0.0223 would signal the recent 1,156.8% 24-hour move is running out of steam.

Technical indicators are mixed. The one confirmed signal is the extreme 24-hour gain of 1,156.8% against a $22.3 million market cap. The setup improves if volume stays elevated and the token holds above $0.0223; a drop in volume or a break below that level would point to weakening demand. The metric to watch: whether HOODIE can sustain buying volume after the 1,156.8% spike.

Frequently Asked Questions

What is HOODIE crypto?

HOODIE is a meme token launched on Robinhood Chain, an Ethereum Layer-2 blockchain designed for onchain finance, real-world assets, and decentralized trading. CoinGecko data shows HOODIE ranked #791 with a market capitalization of $22.3M and a price of $0.0223 as of the latest data, making it a small-cap memecoin where liquidity and community activity are key metrics to track.

Why did HOODIE price go up 1,156.8% in 24 hours?

HOODIE’s 24-hour price surge of 1,156.8% appears linked to a sharp increase in speculative demand and trading activity around the Robinhood Chain meme category. CoinGecko data shows HOODIE reached $0.0223 after the move while remaining 40.6% below its all-time high of $0.0319, so the specific metric to watch is whether daily trading volume remains elevated after the initial spike.

Is HOODIE a good investment?

HOODIE is a high-risk speculative investment because its valuation depends heavily on meme momentum and market participation rather than established cash flows. CoinGecko data shows HOODIE has a $22.3M market cap and only a short trading history relative to larger crypto assets, so investors should monitor market cap growth and holder distribution before treating the token as a long-term position.

Where can I buy HOODIE crypto?

HOODIE can be bought through exchanges or decentralized platforms that support Robinhood Chain assets, depending on current market availability. CoinGecko data shows HOODIE trades around $0.0223 with a $22.3M market cap, so buyers should verify liquidity, trading pairs, and 24-hour volume before executing a purchase.

Ready to start trading?

Trade on Bitget Try CoinTech2u

Affiliate links — we may earn a commission at no extra cost to you.

Our Verdict

HOODIE ranks #791 by market cap at $22.3 million and trades at $0.0223, sitting 40.6% below its $0.0319 all-time high after a 1,156.8% 24-hour surge. Its position on Robinhood Chain gives it a possible catalyst as that ecosystem grows, but a $22.3 million valuation is still small next to established meme coins, which means volatility risk stays high while liquidity builds. Near-term direction hinges on whether the token holds above $0.0223 after this move and can reclaim the $0.0319 ATH. The metric to track is daily trading volume following the 1,156.8% spike.

Related Articles

Sarah Mitchell

Research Analyst

Sarah provides in-depth coin research combining on-chain metrics, fundamentals, and market positioning.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Cryptocurrency investments carry significant risk. Always do your own research and never invest more than you can afford to lose. This article may contain affiliate links.